Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cushing's syndrome without excess cortisol.

× No keyword cloud information.

16 in total

Review 1. The clinical spectrum of pulmonary aspergillosis.

Authors: Ayman O Soubani; Pranatharthi H Chandrasekar
Journal: Chest Date: 2002-06 Impact factor: 9.410

2. Inhaled budesonide induced Cushing's syndrome in cystic fibrosis patients, due to drug inhibition of cytochrome P450.

Authors: Elke De Wachter; Anne Malfroot; Iris De Schutter; Jesse Vanbesien; Jean De Schepper
Journal: J Cyst Fibros Date: 2003-06 Impact factor: 5.482

Review 3. Effects of the antifungal agents on oxidative drug metabolism: clinical relevance.

Authors: K Venkatakrishnan; L L von Moltke; D J Greenblatt
Journal: Clin Pharmacokinet Date: 2000-02 Impact factor: 6.447

4. Acute adrenal insufficiency associated with high dose inhaled steroids.

Authors: J Wong; P Black
Journal: BMJ Date: 1992-05-30

5. Cushing's syndrome due to pharmacological interaction in a cystic fibrosis patient.

Authors: K M Main; M Skov; I B Sillesen; H Dige-Petersen; J Müller; C Koch; S Lanng
Journal: Acta Paediatr Date: 2002 Impact factor: 2.299

6. Effects of repeated once daily dosing of three intranasal corticosteroids on basal and dynamic measures of hypothalamic-pituitary-adrenal-axis activity.

Authors: A M Wilson; L C McFarlane; B J Lipworth
Journal: J Allergy Clin Immunol Date: 1998-04 Impact factor: 10.793

7. Effect of itraconazole on the pharmacokinetics of prednisolone and methylprednisolone and cortisol secretion in healthy subjects.

Authors: B Lebrun-Vignes; V C Archer; B Diquet; J C Levron; O Chosidow; A J Puech; D Warot
Journal: Br J Clin Pharmacol Date: 2001-05 Impact factor: 4.335

Review 8. Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses.

Authors: S M Grant; S P Clissold
Journal: Drugs Date: 1989-03 Impact factor: 9.546

9. Profound adrenal suppression secondary to treatment with low dose inhaled steroids and itraconazole in allergic bronchopulmonary aspergillosis in cystic fibrosis.

Authors: J S Parmar; T Howell; J Kelly; D Bilton
Journal: Thorax Date: 2002-08 Impact factor: 9.139

10. Cushing's syndrome due to interaction between inhaled corticosteroids and itraconazole.

Authors: Mark J Bolland; Warwick Bagg; Mark G Thomas; Jennifer A Lucas; Rob Ticehurst; Peter N Black
Journal: Ann Pharmacother Date: 2004-01 Impact factor: 3.154

7 in total

1. Drug interactions between inhaled corticosteroids and enzymatic inhibitors.

Authors: Amélie Daveluy; Cécile Raignoux; Ghada Miremont-Salamé; Pierre-Olivier Girodet; Nicholas Moore; Françoise Haramburu; Mathieu Molimard
Journal: Eur J Clin Pharmacol Date: 2009-04-28 Impact factor: 2.953

2. The risk benefit ratio of glucocorticoids in SLE: have things changed over the past 40 years?

Authors: G Stojan; M Petri
Journal: Curr Treatm Opt Rheumatol Date: 2017-07-27

Review 3. Inhaled corticosteroid use in HIV-positive individuals taking protease inhibitors: a review of pharmacokinetics, case reports and clinical management.

Authors: P Saberi; T Phengrasamy; D P Nguyen
Journal: HIV Med Date: 2013-04-16 Impact factor: 3.180

Cushing's syndrome without excess cortisol.